Clinical Trial Update: A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of aminolevulinic acid (ALA) to enhance visualization and resection of malignant glial brain tumors (glioma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: Legacy Health System | Conditions: Glioma | Phase 2 | Status: UNKNOWN